Compare ITRM & BILI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ITRM | BILI |
|---|---|---|
| Founded | 2015 | 2009 |
| Country | Ireland | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.3M | 10.8B |
| IPO Year | 2018 | 2018 |
| Metric | ITRM | BILI |
|---|---|---|
| Price | $0.47 | $24.83 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | $9.00 | ★ $30.00 |
| AVG Volume (30 Days) | 1.2M | ★ 2.0M |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.25 |
| Revenue | $390,000.00 | ★ $4,180,323,637.00 |
| Revenue This Year | N/A | $14.69 |
| Revenue Next Year | $325.95 | $9.43 |
| P/E Ratio | ★ N/A | $97.90 |
| Revenue Growth | N/A | ★ 16.95 |
| 52 Week Low | $0.36 | $14.47 |
| 52 Week High | $2.27 | $32.50 |
| Indicator | ITRM | BILI |
|---|---|---|
| Relative Strength Index (RSI) | 47.71 | 39.43 |
| Support Level | $0.44 | $24.81 |
| Resistance Level | $0.48 | $25.48 |
| Average True Range (ATR) | 0.04 | 0.52 |
| MACD | 0.01 | -0.04 |
| Stochastic Oscillator | 58.50 | 22.25 |
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
Bilibili is a Chinese online entertainment platform best known for its YouTube-like video-sharing site. Founded in 2009, it initially focused on long-form content centered around anime, comics, and gaming, catering primarily to Gen Z users. Over time, the platform has broadened its content offerings to include a wider range of interests, successfully attracting a more diverse audience beyond the Gen Z demographic.